US 6063582
Methods of screening for compounds that interact with human P.sub.2u2 purinergic receptor
expired A61KA61K38/00A61K48/00
Quick answer
US patent 6063582 (Methods of screening for compounds that interact with human P.sub.2u2 purinergic receptor) held by COR Therapeutics, Inc. expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K48/00